Durlobactam

CAS No. 1467829-71-5

Durlobactam( Durlobactam )

Catalog No. M12004 CAS No. 1467829-71-5

Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 2043 Get Quote
50MG 4122 Get Quote
100MG 5760 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Durlobactam
  • Note
    Research use only, not for human use.
  • Brief Description
    Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
  • Description
    Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Durlobactam
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1467829-71-5
  • Formula Weight
    277.251
  • Molecular Formula
    C8H11N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(O)(ON1[C@]2([H])C=C(C)[C@@H](C(N)=O)[N@@](C2)C1=O)=O
  • Chemical Name
    (1R,2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl hydrogen sulfate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cefpirome sulfate

    Cefpirome Sulfate is a fourth generation cephalosporin antibiotic.

  • Ligustilide A

    Ligustilide A, an active ingredient isolated from the medicinal plants Angelica acutiloba and Cnidium officinale, inhibits benzo(a)pyrene-induced CYP1A1 upregulation in cultured human keratinocytes via ROS-dependent Nrf2 activation.

  • HMPC

    HMPC is a novel bacteriostatic agent that shows bacteriostatic activity against S. aureus (MIC=4?μg/ml) and rescues Caenorhabditis elegans from S. aureus infection.